Free Research Reports on BIOL, CELG, ILMN and HAR Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY -- (Marketwire) -- 01/08/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

BIOLASE Inc. (NASDAQ: BIOL) shares soared 18.5 percent on more than ten times the average daily volume Monday after reporting that they expect revenues in the fourth quarter to top $18 million, their previous forecast called for revenues to range from $16.5 million and $17.5 million.

Find out more about BIOLASE including full access to the free equity report at: www.BedfordReport.com/BIOL

Celgene Corporation (NASDAQ: CELG) is a global biopharmaceutical company engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases. Shares of the company spiked 4.4 percent Monday after reporting that it forecasts income in 2012 to come in at the top end of their guidance.

Find out more about Celgene including full access to the free equity report at: www.BedfordReport.com/CELG

Illumina, Inc. (NASDAQ: ILMN) shares of the genetic analysis company declined 7 percent on nearly five times the average daily volume Monday. Roche Holding AG Chairman Franz Humer has recently stated that a plan to acquire Illumina is off the table.

Find out more about Illumina including full access to the free equity report at: www.BedfordReport.com/ILMN

Harman International Industries Inc. (NYSE: HAR) shares surged 3 percent on twice the average daily volume Monday. Analysts at Baird have recently upgraded the company's rating to "outperform" as contracts with major auto makers are expected to drive sales growth.

Find out more about Harman International Industries including full access to the free equity report at: www.BedfordReport.com/HAR

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here